Chronic Cough News

The Healio editors have compiled a list of the most-read pulmonology news published in July.

Understanding the breadth of pulmonary complications among patients with rheumatic disease is critical to total patient care, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

A team of researchers created a prognostic nomogram that accurately predicted risk factors associated with mortality in hospitalized patients with COVID-19 based on individual features, according to data published in Chest.

The Healio Editors have compiled a list of the most-read pulmonology news published in June.

A novel P2X3 receptor antagonist, in multiple doses up to 750 mg, was well tolerated, and higher doses significantly reduced cough count and severity compared with placebo in patients with refractory chronic cough.

Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in March.

New data published in The Lancet Respiratory Medicine show that a 50 mg dose of the P2X3 receptor antagonist gefapixant significantly reduced cough frequency in patients with chronic cough when compared with placebo.

During a 2017 wildfire, San Diego hospitals observed an increase in ED visits for breathing problems among children, according to a study published in the Annals of the American Thoracic Society.

HOUSTON — Forced exhaled nitric oxide, or FeNO, may be useful for diagnosing cough variant asthma in patients with chronic cough who have normal spirometry, researchers reported at the American College of Allergy, Asthma and Immunology Annual Meeting.

Among patients with asthma, those with chronic cough vs. without chronic cough had worse respiratory symptoms, more health care use, lower lung function and higher levels of inflammatory biomarkers, according to a Danish study published in the Journal of Allergy and Clinical Immunology: In Practice.